Oceña, Heintje .

HRN: 24-18-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
AZITHROMYCIN 500MG TABLET (TAB)
11/29/2023
12/02/2023
PO
500
OD
Cap
Waiting Final Action 
11/29/2023
CEFTRIAXONE 1G (VIAL)
11/29/2023
12/06/2023
IV
2g
OD
CAP-MR
Waiting Final Action 
12/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2023
12/11/2023
IV
4.5g
Q6
CAP-MR; Immunicompromised State
Waiting Final Action 
12/05/2023
CLARITHROMYCIN 500MG (CAP)
12/05/2023
12/11/2023
ORAL
500 Mg/tab, 1 Tab
Bid
Cap HR ;sepses; Immunocompromised Host
Waiting Final Action 
12/05/2023
FLUCONAZOLE 150MG (CAP)
12/05/2023
12/11/2023
PO
150mg
OD
Cap-HR; Sepsis; Immunocompromised Host
Waiting Final Action 
12/16/2023
FLUCONAZOLE 150MG (CAP)
12/16/2023
12/31/2023
PO
150mg
OD MWF
Immunocompromised State; Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: